Genoma Institute is a nonprofit dedicated to curing genetic disease — building the benchmarks, research, and public understanding that gene editing needs to reach the people waiting on it.
We have the tools. We're flying blind.
46 approved gene therapies exist today — covering less than 1% of the 10,000+ known genetic disorders. There's no shared roadmap, no agreed benchmarks, no real way to compare the tools we already have. The bottleneck isn't the absence of gene editing technology — it's the absence of a framework to evaluate it. That's the gap Genoma exists to close.
A biennial, blind, unbiased competition — the Olympics of gene editing. Benchmarks that let academia and industry compete, compare, and learn.
A focused nonprofit lab developing gene therapies for mitochondrial DNA diseases — tackling age-related and rare disorders no one else is chasing.
A newsletter, podcast, and forum creating a trusted, structured space for public discourse on gene editing, AI in biology, and what it means for humanity.
In every major scientific field, the breakthrough came after someone framed the problem with an open, unbiased benchmark.
Gene editing has the tool. Genoma is building the benchmark.
Your support funds the inaugural CALI competition — the first open benchmark in gene therapy since CASP transformed protein folding.